Abstract
Until the middle of this century, tuberculosis was, in Dickens’ words, ‘a disease which medicine never cured, wealth warded off, or poverty could boast exemption from – which sometimes moves in giant strides, and sometimes at a tardy sluggish pace, but, slow or quick, is ever sure and certain’ [1]. Mycobacterium tuberculosis is an extremely successful pathogen that continues to thrive in developing countries and is re-emerging in the industrialized world. Globally, it remains a more frequent cause of death than any other infectious agent [2]. Approximately a third of the world’s population is infected with M. tuberculosis, and the World Health Organization estimated that in 1996 there were 8 million new cases of tuberculosis and 3 million deaths from the disease [2]. The sinister synergy between this disease of antiquity and the newer pathogen human immunodeficiency virus is responsible for the death of about a third of all patients with AIDS in Africa [3].

This publication has 18 references indexed in Scilit: